Cal. Code Regs. Tit. 8, § 9792.27.23 - Mtus Drug List Updates

(a) The Administrative Director shall consult with the P&T Committee as needed on updates to the MTUS Drug List, which may be adopted by the Administrative Director on a quarterly or more frequent basis in order to allow provision for all appropriate medications.

(b) The P&T Committee is responsible for reviewing and consulting with the Administrative Director on available evidence of the relative safety, efficacy, and effectiveness of drugs within a class of drugs. In carrying out these duties the P&T Committee may provide consultation on a variety of relevant issues, including but not limited to the following:

(1) Recommendations on prospective review requirements for drugs;

(2) Recommendations on Special Fill and Perioperative Fill designation and policies;

(3) Review of drug treatment changes adopted into the MTUS Treatment Guidelines to identify needed additions or deletions of drugs from the MTUS Drug List;

(4) Recommendations on establishing a therapeutic interchange program in order to promote safe and appropriate cost effective care.

(c) The P&T Committee serves in an advisory role only. P&T Committee recommendations are not binding on the Administrative Director.

(d) Updates to the MTUS Drug List will be adopted by issuance of an Administrative Director's order specifying the changes and the effective date, and shall be posted on the division's website pursuant to Labor Code section 5307.29.

Notes

Cal. Code Regs. Tit. 8, § 9792.27.23

1. New section filed 12-7-2017; operative 1-1-2018 pursuant to Government Code section 11343.4(b)(3) (Register 2017, No. 49).

Note: Authority cited: Sections 133, 4603.5, 5307.3 and 5307.27, Labor Code. Reference: Sections 4600, 4604.5, 5307.27 and 5307.29, Labor Code.

1. New section filed 12-7-2017; operative 1/1/2018 pursuant to Government Code section 11343.4(b)(3) (Register 2017, No. 49).